SYDNEY:Some Australian scientists have proposed delaying mass inoculation using AstraZeneca's COVID-19 vaccine with a view to considering a different shot instead.
Questions surrounding the vaccine in Australia, which recorded just one new local case of the coronavirus on Wednesday, have cast a cloud over its immunisation plans, with 53 million doses of the AstraZeneca jab already on order.
Experts cited data showing the AstraZeneca jab had 62% efficacy compared with over 90% for a vaccine developed by Pfizer and its partner BioNTech.
"The question is really whether it (AstraZeneca) is able to provide herd immunity. We are playing a long game here. We don't know how long that will take," said Professor Stephen Turner, president of the Australian and New Zealand Society for Immunology (ASI).
Turner added that the government must pivot towards getting more of the Moderna and Pfizer vaccines.
Earlier, he told the Sydney Morning Herald that the AstraZeneca vaccine is not one "I would be deploying widely because of that lower efficacy."
In a statement, the ASI said Turner was speaking as an expert in immunology and that the body did not advocate a pause to the rollout as widely reported by local media.
Australia has agreed to buy 10 million doses of the Pfizer vaccine, though neither AstraZeneca nor Pfizer have approval from the country's drug regulator, the Therapeutic Goods Administration (TGA).
AstraZeneca did not immediately respond to an email request for comment.
Its vaccine is approved in Britain, India and Argentina and is under review by several other countries including South Korea and Brazil.
'EFFECTIVE, SAFE, HIGH QUALITY'
Australia's chief medical officer, Paul Kelly, attempted to address concerns around the efficacy of the AstraZeneca vaccine, calling it "effective", "safe" and "high quality".
"The great advantage of the AstraZeneca vaccine is it's being made here in Australia," Kelly said. "It will be available as soon as the TGA gives its tick, which we expect that it will in February."
Kelly said Australia would have more data by February as well as "real-world information" coming from London, which has already rolled out the vaccine.
Australia has been more successful than many other countries in managing the pandemic, with total infections in the country of 25 million people at about 28,600, with 909 deaths. (Graphic: https://tmsnrt.rs/34pvUyi)
Its success is largely attributable to closed borders and widespread compliance with social-distancing rules, along with aggressive testing and tracing programmes.
Given the low case numbers and community transmission rates, some experts say Australia could afford to wait for a more effective vaccine.
"The government needs to be flexible in its rollout decisions once we have a better understanding of the efficacy of the other vaccines," said Adrian Esterman, chair of Biostatistics and Epidemiology at the University of South Australia.
Australia recorded one new local coronavirus case in its most populous state of New South Wales on Wednesday.
In Queensland, hundreds of hotel quarantine guests were forced to restart their isolation after a handful of cases in the facility were linked to the highly contagious UK virus strain.
Reuters
Wed Jan 13 2021
Pedestrians cross a street in the city centre as the state of New South Wales continues to report low case numbers of the coronavirus disease (COVID-19) in Sydney, Australia, October 26, 2020. REUTERS/Loren Elliott
SDG: UTP lahir pelajar berkemahiran, tinggi tanggungjawab sosial
UTP berhasrat mendidik pelajar bukan sahaja untuk mahir dalam aspek teknikal tetapi juga untuk menjadi warganegara yang bertanggungjawab.
MAA semak semula unjuran jualan kenderaan 2024 kepada 765,000 unit
Persatuan Automotif Malaysia (MAA) telah menyemak semula unjuran jualan kenderaan bermotor baharu bagi 2024 kepada 765,000 unit daripada anggaran sebelumnya sebanyak 740,000 unit.
RUU 355: Pindaan perlu untuk praktikaliti, keadilan
Apa sahaja pindaan terhadap akta itu perlu berjalan selari dengan persediaan mereka yang bertanggungjawab melaksanakannya.
Rasionalisasi RON95 dijangka beri impak lebih besar kepada PKS - SAMENTA
SAMENTA menjangkakan rasionalisasi RON95 akan memberi impak yang lebih besar kepada perusahaan kecil dan sederhana (PKS) berbanding pelarasan subsidi diesel.
Malaysia sasar pengeluaran 40 peratus sektor akuakultur menjelang 2030
Malaysia menyasarkan pengeluaran 40 peratus hasil sektor akuakultur menjelang 2030 dalam usaha membantu mengimbangi keperluan perikanan negara.
10 Berita Pilihan - (16 Julai 2024
Antara pelbagai berita dalam dan luar negara yang disiarkan di Astro AWANI, berikut adalah yang paling menjadi tumpuan sepanjang hari ini.
PAC beri tempoh tiga bulan kepada HRD Corp
Jawatankuasa Kira-kira Wang Negara (PAC) memberi tempoh tiga bulan kepada Perbadanan Pembangunan Sumber Manusia (HRD Corp) untuk mengemukakan laporan tindakan susulan terhadap syor jawatankuasa itu.
Kylian Mbappe tandatangan kontrak dengan Real Madrid
Bintang bola sepak Perancis Kylian Mbappe menandatangani kontrak selama lima tahun dengan kelab Sepanyol Real Madrid pada Selasa.
Pelepasan ketujuh air sisa nuklear Fukushima ke laut selesai
Jepun telah menyelesaikan pusingan ketujuh pelepasan air sisa radioaktif yang dirawat dari loji kuasa nuklear Fukushima Daiichi ke Lautan Pasifik pada Selasa.
Empat termasuk kapten maut dalam pertempuran
Empat anggota tentera India termasuk kapten meninggal dunia akibat kecederaan selepas pertempuuran pada malam isnin di Hutan Desa.
‘Kes darah beku, serangan jantung tiada kaitan dengan vaksin AstraZeneca’
Golongan berisiko tinggi adalah individu yang mempunyai sejarah pembekuan darah dan mereka tidak dibenarkan menerima vaksin jenis AZ.
KKM keluar kenyataan berkaitan vaksin AstraZeneca dalam masa terdekat
KKM akan mengeluarkan kenyataan berhubung isu penarikan balik vaksin COVID-19 keluaran AstraZeneca dalam masa terdekat.
Berita antarabangsa pilihan sepanjang hari ini
Antara pelbagai berita luar negara yang disiarkan di Astro AWANI, berikut adalah antara yang paling menjadi tumpuan sepanjang hari ini.
AstraZeneca tarik balik vaksin COVID-19 di seluruh dunia, berbulan selepas sedar ada kesan sampingan
Vaksin itu tidak lagi boleh digunakan di EU selepas syarikat itu secara sukarela menarik balik "kebenaran pemasarannya."
KKM beri jaminan dedah data AEFI vaksin COVID-19 - Dr Dzulkefly
KKM memberi jaminan akan mendedahkan semua data berhubung kesan sampingan susulan imunisasi (AEFI) yang berpunca daripada vaksin COVID-19 pada satu waktu yang akan ditetapkan.
Tiada kesan sampingan daripada vaksin COVID-19 AstraZeneca di Indonesia - Suruhanjaya
Suruhanjaya Nasional untuk Kajian dan Pencegahan Peristiwa Mudarat Berikutan Imunisasi dan BPOM melakukan pemantauan bagi membuat rumusan.
Kesan sampingan vaksin: KKM akan dapatkan penjelasan AstraZeneca
Kementerian Kesihatan (KKM) akan mendapatkan penjelasan daripada firma farmaseutikal AstraZeneca berhubung kesan sampingan vaksin COVID-19 seperti yang dilaporkan media antarabangsa baru-baru ini.
AstraZeneca berjaya batalkan saman 12 individu berhubung isu suntikan vaksin COVID-19
Hakim Mahkamah Tinggi Dr Suzana Muhamad Said membenarkan permohonan Astrazeneca untuk membatalkan saman itu selepas mendengar hujahan kedua-dua pihak.
AstraZeneca rintis inisiatif kesaksamaan akses dalam perkhidmatan kesihatan
Portal mySihatPal menutup jurang akses kepada penyelesaian penjagaan kesihatan.
AstraZeneca tumpu kepada kepada penyakit jarang jumpa, teruskan pelaburan tempatan
AstraZeneca berhasrat menjadi pengupaya penyelesaian yang bekerjasama dalam aspek berbeza kepada pesakit.